Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany

被引:0
|
作者
Tjalf Ziemssen
Michael Lang
Stephan Schmidt
Holger Albrecht
Luisa Klotz
Judith Haas
Christoph Lassek
Stefan Lang
Veronika E. Winkelmann
Benjamin Ettle
Ulf Schulze-Topphoff
机构
[1] University of Technology,Center of Clinical Neuroscience, Neurological University Clinic Carl Gustav Carus
[2] NeuroPoint Patient Academy and Neurological Practice,Department of Neurology
[3] Health Center St. Johannes,Center for Multiple Sclerosis
[4] Neurological Practice,undefined
[5] University Hospital Münster,undefined
[6] Jewish Hospital Berlin,undefined
[7] Neurological Practice,undefined
[8] Kassel and Vellmar,undefined
[9] Scientific and Medical Writing,undefined
[10] Novartis Pharma GmbH,undefined
来源
Journal of Neurology | 2022年 / 269卷
关键词
Relapsing–remitting multiple sclerosis; Fingolimod; Real-world; Safety; Effectiveness;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3276 / 3285
页数:9
相关论文
共 50 条
  • [31] Long term effectiveness and safety of ocrelizumab in a real-world setting: a single center experience
    Guerra, Tommaso
    Caputo, Francesca
    Manni, Alessia
    Trojano, Maria
    Paolicelli, Damiano
    Iaffaldano, Pietro
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 959 - 960
  • [32] Long-term effectiveness of bisoprolol in patients with angina: A real-world evidence study
    Sabido, M.
    Hohenberger, Thilo
    Grassi, Guido
    PHARMACOLOGICAL RESEARCH, 2019, 139 : 106 - 112
  • [33] Long-Term Evaluation of Effectiveness and Immunological Implications of Ocrelizumab in a Real-World Cohort
    Guerra, Tommaso
    Caputo, Francesca
    Bianco, Antonella
    Paolicelli, Damiano
    Iaffaldano, Pietro
    DRUGS-REAL WORLD OUTCOMES, 2025,
  • [34] Ongoing Safety and Effectiveness: An Interim Analysis of Long-Term Fingolimod Treatment
    Cohen, Jeffrey
    Pradhan, Ashish
    Gothschalk, Rebecca
    Chen, Yu
    Kappos, Ludwig
    NEUROLOGY, 2016, 86
  • [35] Real-world evidence on the safety and effectiveness of fingolimod in patients with multiple sclerosis from Taiwan
    Yang, Chih-Chao
    Ro, Long-Sun
    Tsai, Nai-Wen
    Lin, Chou-Ching
    Huang, Wen-Nan
    Tsai, Ching-Piao
    Lin, Thy-Sheng
    Su, Jen-Jen
    Huang, Chin-Chang
    Lyu, Rong-Kuo
    Chen, Hsin-Hua
    Lee, Wei-Ju
    Chen, Po-Lin
    Yang, Audrey
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021, 120 (01) : 542 - 550
  • [36] LONG-TERM EFFECTIVENESS AND SAFETY OF LOMITAPIDE: REAL-WORLD EXPERIENCE FROM ITALY IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Suppressa, P.
    Coppola, C.
    Cocco, V.
    O'Brien, S.
    Stanzione, C.
    De Ruberto, F.
    Lannuzzo, G.
    ATHEROSCLEROSIS, 2023, 379
  • [37] Long-Term Safety and Effectiveness of Diquafosol for the Treatment of Dry Eye in a Real-World Setting: A Prospective Observational Study
    Yuichi Ohashi
    Masahiro Munesue
    Jun Shimazaki
    Etsuko Takamura
    Norihiko Yokoi
    Hitoshi Watanabe
    Akio Nomura
    Fumiki Shimada
    Advances in Therapy, 2020, 37 : 707 - 717
  • [38] Long-Term Effectiveness and Safety of Ustekinumab for The Treatment of Crohn′s Disease: A Brazilian Multicentre Real-world Study
    Oleg, Knyazev
    Albina, Lishchinskaya
    Anatoliy, Konoplyannikov
    Anna, Kagramanova
    Nina, Fadeeva
    Dmitriy, Kulakov
    Anait, Babayan
    Mariya, Zvyaglova
    Asfold, Parfenov
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S2 - S2
  • [39] Long-term effectiveness and safety of lacosamide as adjunctive therapy in children and adolescents with refractory epilepsy: a real-world study
    Zhao, Ting
    Yu, Lu-hai
    Zhang, Hui-lan
    Yu, Jing
    Feng, Jie
    Wang, Ting-ting
    Sun, Yan
    Li, Hong-jian
    BMC PEDIATRICS, 2023, 23 (01)
  • [40] Long-Term Safety and Effectiveness of Diquafosol for the Treatment of Dry Eye in a Real-World Setting: A Prospective Observational Study
    Ohashi, Yuichi
    Munesue, Masahiro
    Shimazaki, Jun
    Takamura, Etsuko
    Yokoi, Norihiko
    Watanabe, Hitoshi
    Nomura, Akio
    Shimada, Fumiki
    ADVANCES IN THERAPY, 2020, 37 (02) : 707 - 717